Tessera Defense and Homeland Security Inc.

Análisis de la acción Tessera Defense and Homeland Security Inc. (HLSQ)

$0.134

+0.011 (+8.06%)Al cierre

Loading chart…
Máximo
0.147
Apertura
0.142
Precio medio ponderado por volumen
0.14
Volumen
310.94K
Capitalización
—
Mínimo
0.130
Importe
42.61K
EV/EBITDA, TTM
0.00

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

thlsq.ai

Análisis de IA of Tessera Defense and Homeland Security Inc. (HLSQ)

Vender

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Métricas de valoración

El PER previsto actual de Tessera Defense and Homeland Security Inc. (HLSQ) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E
P/E actual
0.00

EV/EBITDA previsto

Media 5A EV/EBITDA
EV/EBITDA actual
0.00

Precio/ventas previsto

Media 5A P/S
P/S actual
0.00

Cronología de eventos

2026-10-20 (ET)

08:30:00

Zorronet Receives Initial Order from Global Defense Company

2026-10-15 (ET)

10:00:00

Tessera Defense Secures Option to Acquire Controlling Stake in RT LTA Systems

Noticias

Preguntas frecuentes sobre HLSQ, respondidas por Alphio AI

Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.

BiomX Inc is not a good buy right now due to its extremely low current price of 0.13, a staggering year-to-date change of -92.75%, and a very low RSI of 20.515 indicating oversold conditions. The company has reported zero revenue for multiple quarters, and its gross margin is only 29.22%. The main risk is its negative net income of -3,772,000 USD in the most recent quarter, which raises concerns about its financial viability.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar